regulators < regulatory < rehabilitative

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]

Ident.	Authors (with country if any)	Title
000039 (2011)	Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]	Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000125 (2012)	Nicolas Rohleder [États-Unis] ; Martin Aringer [Allemagne] ; Matthias Boentert [Allemagne]	Role of interleukin‐6 in stress, sleep, and fatigue
000173 (2013)	Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]	Aryl hydrocarbon receptor and experimental autoimmune arthritis
000181 (2015)	Yi Zhang [États-Unis] ; Xiaohui Wei [États-Unis] ; Gaurav Bajaj [États-Unis] ; Jeffrey S. Barrett [États-Unis] ; Bernd Meibohm [États-Unis] ; Amita Joshi [États-Unis] ; Manish Gupta [États-Unis]	Challenges and considerations for development of therapeutic proteins in pediatric patients
000225 (2012)	K M Hull [États-Unis] ; S. Yim [États-Unis]	Regulatory Aspects of New Medicines Targeted at Treatment of Autoimmune Diseases
000278 (2013)	Frédéric Perros [France] ; Marc Humbert [France] ; Sylvia Cohen-Kaminsky [France]	Hypertension artérielle pulmonaire
000462 (2013)	Reinhard P. T. Rychlik [Allemagne]	Target patient population: how does the regulatory and reimbursement view differ? Insights from the German IQWiG
000584 (2012)	Chia Chi Sun [États-Unis] ; Valentina Vaja [États-Unis, Italie] ; Jodie L. Babitt [États-Unis] ; Herbert Y. Lin [États-Unis]	Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
000595 (2013)	Allan Thiolat [France] ; Jerome Biton [France] ; Luca Semerano [France] ; Yves-Marie Pers [France] ; Pierre Portales [France] ; Delphine Lemeiter [France] ; Patrice Decker [France] ; Christian Jorgensen [France] ; Marie-Christophe Boissier [France] ; Pascale Louis-Plence [France] ; Natacha Bessis [France]	A3.10 IL-6 Receptor Blockade Enhances CD39+ Regulatory T-Cell Development in Rheumatoid Arthritis and in Experimental Arthritis
000612 (2014)	Andrew T. Chow [États-Unis] ; Justin C. Earp [États-Unis] ; Manish Gupta [États-Unis] ; William Hanley [États-Unis] ; Chuanpu Hu [États-Unis] ; Diane D. Wang [États-Unis] ; Stefan Zajic [États-Unis] ; Min Zhu [États-Unis]	Utility of population pharmacokinetic modeling in the assessment of therapeutic protein‐drug interactions
000643 (2013)	A. Rose [Allemagne] ; Jy Humrich [Allemagne] ; G. Riemekasten [Allemagne]	A3.12 Intrarenal Foxp3+ Regulatory T Cells Expansion and Decreased Number of Infiltrating CD4+ T Cells in Murine Lupus by IL-2 Therapy
000716 (2013)	Jayesh Pandya [Suède] ; Mohammad Shahadat Hossain [Suède] ; Ingrid E. Lundberg [Suède] ; Vivianne Malmström [Suède]	A3.11 Immunosuppressive Effects of Glucocorticoids and Regulatory T Cells on CD28null T Cells in Vitro
000892 (2013)	C. I. Daien ; S. Gailhac ; T. Mura [France] ; B. Combe ; M. Hahne ; J. Morel	FRI0221 Tocilizumab increases regulatory t cells and nk cells cytotoxicity in rheumatoid arthritis patients
000956 (2009)	Larry W. Moreland [États-Unis]	Cytokines as Targets for Anti‐inflammatory Agents
000B67 (2012)	Sandeep Kumar [États-Unis] ; Mark A. Mitchell [États-Unis] ; Bonita Rup [États-Unis] ; Satish K. Singh [États-Unis]	Relationship between potential aggregation‐prone regions and HLA‐DR‐binding T‐cell immune epitopes: Implications for rational design of novel and follow‐on therapeutic antibodies
000C14 (2013)	A. Thiolat ; J. Biton ; L. Semerano [France] ; D. Lemeiter ; M.-C. Boissier [France] ; N. Bessis	SAT0042 Treatment by anti-IL-6 receptor acts on CD4+ FOXP3+ regulatory t cells in a model of rheumatoid arthritis
000D23 (2012)	Marinos C. Dalakas [États-Unis, Grèce]	Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future
000D28 (2010)	Valeria Dubinsky [Argentine, Allemagne] ; Tobias G. Poehlmann [Allemagne] ; Pankaj Suman [Inde] ; Teresa Gentile [Argentine] ; Udo R. Markert [Allemagne] ; Gabriela Gutierrez [Argentine, Allemagne]	ORIGINAL ARTICLE: Role of Regulatory and Angiogenic Cytokines in Invasion of Trophoblastic Cells
000E37 (2011)	Meredith A. Atkinson [États-Unis] ; Colin T. White [Canada]	Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist
000E88 (2016)	Jean-David Zeitoun [France] ; Jérémie H. Lefèvre [France] ; Nicholas S. Downing [États-Unis] ; Henri Bergeron [France] ; Joseph S. Ross [États-Unis]	Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross‐sectional study
000E90 (2011)	April W. Armstrong [États-Unis] ; Stephanie V. Voyles [États-Unis] ; Ehrin J. Armstrong [États-Unis] ; Erin N. Fuller [États-Unis] ; John C. Rutledge [États-Unis]	A tale of two plaques: convergent mechanisms of T‐cell‐mediated inflammation in psoriasis and atherosclerosis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "regulatory" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "regulatory" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    regulatory
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021